The paper reports the results of a retrospective observational study assessing adverse events and changes in glucose control (verified with the use of continuous glucose monitoring system) after vaccination for COVID19 in patients with type 2 diabetes.
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) / Dicembrini I.; Vitale V.; Cosentino C.; Cresci B.; Pala L.; Pieri M.; Yannas D.; Vannucci M.; Zago E.; Romani A.; Delli Poggi C.; Mariani S.L.; Scoccimarro D.; Cocchetti C.; Monami M.; Mannucci E.. - In: ACTA DIABETOLOGICA. - ISSN 0940-5429. - STAMPA. - 59:(2022), pp. 435-438. [10.1007/s00592-021-01837-0]
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS)
Dicembrini I.;Cosentino C.;Cresci B.;Pala L.;Yannas D.;Vannucci M.;Zago E.;Delli Poggi C.;Mariani S. L.;Scoccimarro D.;Cocchetti C.;Monami M.;Mannucci E.
2022
Abstract
The paper reports the results of a retrospective observational study assessing adverse events and changes in glucose control (verified with the use of continuous glucose monitoring system) after vaccination for COVID19 in patients with type 2 diabetes.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
